Single Cell Proteomics to Spatial Multiomics in Cardiovascular Disease: Foundations, Technologies, and Biological Insights.
Circ Res.
2026 Jul 31;139(4):e327684. doi: 10.1161/CIRCRESAHA.126.327684. Epub 2026 Jul 30. Review. PubMed PMID:
42531358; NIHMSID:NIHMS2191220.
Actin cytoskeletal dynamics in hepatic myofibroblasts and fibrosis.
Nat Rev Gastroenterol Hepatol.
2026 Jun 29;. doi: 10.1038/s41575-026-01223-7. [Epub ahead of print] Review. PubMed PMID:
42373855.
Atrial fibrillation in patients with alcohol-associated hepatitis leads to increased mortality.
Eur J Gastroenterol Hepatol.
2026 Aug 1;38(8):971-976. doi: 10.1097/MEG.0000000000003223. Epub 2026 Jun 25. PubMed PMID:
42335427.
Laparoscopic liver biopsy for safe tissue acquisition in suspected PSVD or NCPF.
J Hepatol.
2026 Jun 20;. doi: 10.1016/j.jhep.2026.06.020. [Epub ahead of print] PubMed PMID:
42323022.
Adherence to 2020 US Multi-Society Task Force Guidelines for Post-Polypectomy Surveillance: a Multicenter Real-Time Analysis.
J Gastrointest Cancer.
2026 Jun 20;57(1). doi: 10.1007/s12029-026-01486-y. PubMed PMID:
42322361; PubMed Central PMCID:
PMC13283136.
The impact of COVID-19 on alcohol-associated hepatitis and alcohol-associated cirrhosis.
Am J Med Sci.
2026 Sep;372(3):245-249. doi: 10.1016/j.amjms.2026.06.018. Epub 2026 Jun 19. PubMed PMID:
42320714.
Caregiver Involvement and Burden and Patient Quality of Life in Patients With Decompensated Cirrhosis.
Am J Gastroenterol.
2026 Jun 9;. doi: 10.14309/ajg.0000000000004076. [Epub ahead of print] PubMed PMID:
42262375.
An international multidisciplinary consensus statement on laparoscopic liver biopsy.
Cell Rep Med.
2026 Jun 16;7(6):102831. doi: 10.1016/j.xcrm.2026.102831. Epub 2026 May 22. PubMed PMID:
42173098; PubMed Central PMCID:
PMC13293958.
Iron deficiency anemia in patients with cirrhosis.
Am J Med Sci.
2026 Apr 29;. doi: 10.1016/j.amjms.2026.04.010. [Epub ahead of print] PubMed PMID:
42066957.
Stabilizing and strengthening the US physician-scientist faculty workforce in academic medicine: a proposed institutional framework.
JCI Insight.
2026 Jun 22;11(12). doi: 10.1172/jci.insight.205939. eCollection 2026 Jun 22. PubMed PMID:
42048164; PubMed Central PMCID:
PMC13313495.
The effect of SGLT-2 inhibitors on portal hypertensive complications and mortality in patients with cirrhosis.
Am J Med.
2026 Oct;139(10):1365-1374. doi: 10.1016/j.amjmed.2026.04.019. Epub 2026 Apr 17. PubMed PMID:
42002195.
Response to Letters to the Editor Regarding 'Terlipressin for Hepatorenal Syndrome in Patients With Early-Stage Acute-On-Chronic Liver Failure'.
Liver Int.
2026 Apr;46(4):e70588. doi: 10.1111/liv.70588. PubMed PMID:
41814537.
Saffron Alters Microbial Amino Acid Metabolism and Neurotransmitter Production in a Defined Gut Consortium.
Food Sci Nutr.
2026 Apr;14(4):e71694. doi: 10.1002/fsn3.71694. eCollection 2026 Apr. PubMed PMID:
41948379; PubMed Central PMCID:
PMC13052059.
Beta 2 adrenergic receptor agonists as a treatment for metabolic dysfunction-associated steatohepatitis (MASH).
NPJ Metab Health Dis.
2026 Mar 25;4(1). doi: 10.1038/s44324-026-00108-2. PubMed PMID:
41882076; PubMed Central PMCID:
PMC13018619.
Predictors of Short and Long-term Rebleeding in Patients With Overt Gastrointestinal Bleeding: A Prospective Study.
J Clin Gastroenterol.
2026 Mar 1;60(3):273-279. doi: 10.1097/MCG.0000000000002152. PubMed PMID:
39998934.
Overuse of Intravenous Proton-Pump Inhibitors in the Treatment of Low-Risk Upper Gastrointestinal Bleeding.
J Clin Gastroenterol.
2026 Mar 1;60(3):268-272. doi: 10.1097/MCG.0000000000002211. PubMed PMID:
40549584; NIHMSID:NIHMS2086084.
Clinical Outcomes in Patients with Primary Sclerosing Cholangitis With and Without Inflammatory Bowel Disease.
Dig Dis Sci.
2026 Jul;71(7):2848-2856. doi: 10.1007/s10620-026-09699-8. Epub 2026 Feb 6. PubMed PMID:
41649752.
The utility of albumin in cirrhosis: established benefits and unanswered questions.
Curr Opin Gastroenterol.
2026 May 1;42(3):114-120. doi: 10.1097/MOG.0000000000001155. Epub 2026 Jan 29. Review. PubMed PMID:
41912347.
MUC2 shifts the metabolic profiles of commensal bacteria in defined microbial communities.
Microbiome Res Rep.
2026;5(1):1. doi: 10.20517/mrr.2025.91. eCollection 2026. PubMed PMID:
42007376; PubMed Central PMCID:
PMC13091087.
Proton pump inhibitors have no effect on short or long term rebleeding or mortality in patients with overt gastrointestinal bleeding.
Sci Rep.
2025 Dec 29;15(1):44728. doi: 10.1038/s41598-025-28406-7. PubMed PMID:
41462416; PubMed Central PMCID:
PMC12749860.
Clinical outcomes in patients with MASLD with alcohol use disorder.
J Diabetes Metab Disord.
2026 Jun;25(1):11. doi: 10.1007/s40200-025-01737-y. eCollection 2026 Jun. PubMed PMID:
41451397; PubMed Central PMCID:
PMC12728135.
Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With Alpha-1 Antitrypsin Deficiency-Associated Liver Disease.
Gastroenterology.
2026 Apr;170(4):829-842. doi: 10.1053/j.gastro.2025.12.012. Epub 2025 Dec 11. PubMed PMID:
41390004.
Effects of zibotentan and dapagliflozin combined in patients with compensated cirrhosis: A randomized placebo-controlled exploratory study.
Br J Clin Pharmacol.
2026 May;92(5):1326-1338. doi: 10.1002/bcp.70332. Epub 2025 Dec 8. PubMed PMID:
41362018.
Terlipressin for Hepatorenal Syndrome in Patients With Early-Stage Acute-on-Chronic Liver Failure.
Liver Int.
2025 Dec;45(12):e70399. doi: 10.1111/liv.70399. PubMed PMID:
41200852; PubMed Central PMCID:
PMC12593294.
Lactulose-induced Hypernatremia in Cirrhotic Patients With Hepatic Encephalopathy.
J Clin Gastroenterol.
2025 Nov 20;. doi: 10.1097/MCG.0000000000002230. [Epub ahead of print] PubMed PMID:
41525261.
Use of machine learning for early prediction of short-term mortality in veterans with metabolic dysfunction-associated steatotic liver disease.
PLoS One.
2025;20(10):e0334715. doi: 10.1371/journal.pone.0334715. eCollection 2025. PubMed PMID:
41144490; PubMed Central PMCID:
PMC12558492.
The association of race with time to severe liver disease diagnoses.
PLoS One.
2025;20(10):e0334016. doi: 10.1371/journal.pone.0334016. eCollection 2025. PubMed PMID:
41086163; PubMed Central PMCID:
PMC12520358.
Alcoholic Cirrhosis in the Hispanic Population of the United States: A Retrospective Analysis.
Gastroenterology Res.
2025 Oct;18(5):239-246. doi: 10.14740/gr2067. eCollection 2025 Oct. PubMed PMID:
41211070; PubMed Central PMCID:
PMC12591224.
Time to endoscopy and its effect on outcomes in acute nonvariceal and variceal upper gastrointestinal bleeding.
J Investig Med.
2026 Jun;74(5):515-521. doi: 10.1177/10815589251386727. Epub 2025 Sep 29. PubMed PMID:
41024323.
The Impact of COVID-19 on Alcohol-related Morbidity and Mortality: A Multicenter Study.
J Community Hosp Intern Med Perspect.
2025;15(5):12-17. doi: 10.55729/2000-9666.1533. eCollection 2025. PubMed PMID:
41789214; PubMed Central PMCID:
PMC12959132.
Board Certification in the US-Time for a Change?!.
Am J Med.
2025 Sep;138(9):e189. doi: 10.1016/j.amjmed.2025.04.025. PubMed PMID:
40885588.
Impact of Levothyroxine on Progression to and Complications of Cirrhosis in MASH.
Dig Dis Sci.
2025 Oct;70(10):3538-3545. doi: 10.1007/s10620-025-09375-3. Epub 2025 Aug 30. PubMed PMID:
40884700.
Reply to "Questions regarding comparison of 24 vs 72-hr octreotide infusion in acute esophageal variceal hemorrhage: A multi-center RCT".
Am J Med Sci.
2026 Jan;371(1):99. doi: 10.1016/j.amjms.2025.08.015. Epub 2025 Aug 21. PubMed PMID:
40848915.
Severe Alcohol-Related Liver Disease Following Bariatric Surgery.
Clin Obes.
2025 Dec;15(6):e70041. doi: 10.1111/cob.70041. Epub 2025 Aug 20. PubMed PMID:
40836637.
Research Communication: The Risk and Outcomes of Gastrointestinal Bleeding in Patients Using Warfarin or Direct Oral Anticoagulants.
Aliment Pharmacol Ther.
2026 Jan;63(2):299-302. doi: 10.1111/apt.70329. Epub 2025 Aug 13. PubMed PMID:
41459634.
Editorial: Cephalosporin-Induced Liver Injury-Interesting but Tricky. Authors' Reply.
Aliment Pharmacol Ther.
2025 Nov;62(10):1038-1039. doi: 10.1111/apt.70331. Epub 2025 Aug 12. PubMed PMID:
40793870; PubMed Central PMCID:
PMC12584584.
The Impact of COVID-19 and COVID-19 Vaccination on Detection, Assessment, and Management of Suspected Acute Drug-Induced Liver Injury Occurring during Clinical Trials: Consensus Recommendations from the IQ DILI Initiative.
Drug Saf.
2026 Jan;49(1):9-25. doi: 10.1007/s40264-025-01591-0. Epub 2025 Aug 5. Review. PubMed PMID:
40762948; PubMed Central PMCID:
PMC12804223.
Clinical and Genetic Associations in Cephalosporin-Induced Liver Injury: Insights From the Drug-Induced Liver Injury Network.
Aliment Pharmacol Ther.
2025 Nov;62(10):1012-1022. doi: 10.1111/apt.70284. Epub 2025 Jul 20. PubMed PMID:
40685563; PubMed Central PMCID:
PMC12543336.
Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) at Risk for Advanced Fibrosis in a Real-World Primary Care Setting: A Cross-Sectional Study.
J Gen Intern Med.
2026 Jan;41(1):103-110. doi: 10.1007/s11606-025-09659-4. Epub 2025 Jul 7. PubMed PMID:
40624322; PubMed Central PMCID:
PMC12855709.
Risk scoring systems to predict in-hospital mortality in patients with cirrhosis admitted with acute upper gastrointestinal bleeding.
J Investig Med.
2026 Apr;74(3):260-268. doi: 10.1177/10815589251357622. Epub 2025 Jun 30. PubMed PMID:
40586355.
An insider's guide to understanding and obtaining an NIH K career development award.
JCI Insight.
2025 Jun 23;10(12). doi: 10.1172/jci.insight.191904. eCollection 2025 Jun 23. PubMed PMID:
40548379; PubMed Central PMCID:
PMC12220936.
Increased susceptibility to vibrio vulnificus infection in patients with MASLD, cirrhosis, and chronic liver diseases.
Am J Med Sci.
2025 Sep;370(3):305-307. doi: 10.1016/j.amjms.2025.06.002. Epub 2025 Jun 5. PubMed PMID:
40482969.
Vasomics of the liver.
Gut.
2025 May 7;74(6):1008-1020. doi: 10.1136/gutjnl-2024-334133. Review. PubMed PMID:
40044498; PubMed Central PMCID:
PMC12229081.
Management of iron deficiency in children, adults, and pregnant individuals: evidence-based and expert consensus recommendations.
Lancet Haematol.
2025 May;12(5):e376-e388. doi: 10.1016/S2352-3026(25)00038-9. Review. PubMed PMID:
40306833.
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis.
N Engl J Med.
2025 Jun 5;392(21):2089-2099. doi: 10.1056/NEJMoa2413258. Epub 2025 Apr 30. PubMed PMID:
40305708.
Aminotransferase levels in clinical practice - what is normal?.
Curr Opin Gastroenterol.
2025 Jul 1;41(4):260-264. doi: 10.1097/MOG.0000000000001094. Epub 2025 Apr 9. Review. PubMed PMID:
40227983.
The Utility of Multitarget Stool DNA Testing in Community-Based Clinical Practice.
Am J Gastroenterol.
2026 Feb 1;121(2):441-445. doi: 10.14309/ajg.0000000000003480. Epub 2025 Apr 8. PubMed PMID:
40197618.
Paving the physician-scientist career path: from grassroots gathering to national forum.
JCI Insight.
2025 Apr 8;10(7). doi: 10.1172/jci.insight.192689. PubMed PMID:
40197362; PubMed Central PMCID:
PMC11981613.
Systematic review of technical factors associated with persistent fistula after EUS-directed transgastric ERCP in patients with Roux-en-Y gastric bypass.
Gastrointest Endosc.
2025 Nov;102(5):652-661. doi: 10.1016/j.gie.2025.03.1331. Epub 2025 Apr 8. PubMed PMID:
40210021; PubMed Central PMCID:
PMC13511755.
Screening and management of portal hypertension and varices in cirrhosis: Expert perspectives.
Hepatol Commun.
2025 Apr 1;9(4). doi: 10.1097/HC9.0000000000000682. eCollection 2025 Apr 1. Review. PubMed PMID:
40178492; PubMed Central PMCID:
PMC11970884.
What would you like to do?